Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 11, 2022
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $14 on, May 11th, 2022
Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $20 to $14 on, May 11th, 2022.
Puneet has made no other calls on ABCL in the last 4 months.
There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.
This is the rating of the analyst that currently disagrees with Puneet
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $40 on, Friday, February 25th, 2022
